Minimally Invasive Thoracic Surgery Market Introduction and Overview
According to SPER Market Research, the Global Minimally Invasive Thoracic Surgery Market is estimated to reach USD 8.07 billion by 2034 with a CAGR of 6.06%.
The report includes an in-depth analysis of the Global Minimally Invasive Thoracic Surgery Market, including market size and trends, product mix, Applications, and supplier analysis. The global minimally invasive thoracic surgery market was valued at USD 4.48 billion in 2024 and is predicted to grow at a CAGR of 6.06% between 2025 and 2034. The rising number of lung cancer cases fuels demand for better patient treatment, resulting in market expansion and transformation. This expansion is also fueled by changing patient preferences, which need better accommodations, daily routines, check-ups, and stronger patient-hospital staff interactions.
By Type Insights: The lobectomy segment generated significant revenue in 2024. The increase in lobectomy procedures is linked to more cases of lung diseases like lung cancer and chronic obstructive pulmonary disease (COPD), which often require this surgery. Advances in surgical techniques and safer tools have made lobectomy a preferred choice for thoracic surgeries. This segment is the fastest-growing in the market due to shorter hospital stays, less postoperative pain, and quicker recovery times compared to traditional open surgery.
By Regional Insights: North America accounted for about half of the global market in 2024 due to a number of important factors. These include developments in medical technology, which have resulted in the development of novel products that fulfill patient demands. Furthermore, the availability of a competent surgical workforce, the continuous introduction of innovative medical technologies, and well-established regulatory and compensation structures have all helped to the market's expansion in this region.
Market Competitive Landscape
The market for minimally invasive thoracic surgery is experiencing significant growth and development due to a few major companies, particularly in the fields of robots, laparoscopic systems, and non-visual imaging technologies. Key participants in the market include Intuitive Surgical, Medtronic, Smith & Nephew, Johnson & Johnson, and Stryker. These firms have made significant investments in research and development as well as the integration of new technologies to improve minimally invasive surgical systems. Other significant suppliers include, among others, Zimmer Biomet, Karl Storz, and Olympus Corporation. Additionally, these businesses are collaborating with medical professionals, research institutes, and hospitals to advance the use of minimally invasive procedures in thoracic surgery.
Recent Developments:
- The MONARCH Platform and MONARCH Bronchoscope from Johnson & Johnson MedTech were approved by Chinese regulators in November 2023, marking a significant breakthrough in minimally invasive surgical technology. With this approval, the MONARCH system becomes the first robotically assisted platform available in China for peripheral lung surgeries.
- Medtronic plc's Aurora EV-ICD systems were authorized by the FDA in October 2023 to treat extremely fast heart rhythms that might cause sudden cardiac arrest (SCA). These devices resemble conventional ICDs in size, however they are implanted with a minimally invasive technique, placing the lead beneath the breastbone beneath the left armpit.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type.
|
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Medtronic, Dextera Surgical Inc, Intuitive surgical Operations, Inc, Richard Wolf GmBH Grena Ltd, Medela, LivaNova PLC, Teleflex Incorporated, Sklar Surgical Instruments. |
Key Topics Covered in the Report:
- Global Minimally Invasive Thoracic Surgery Market Size (FY’2021-FY’2034)
- Overview of Global Minimally Invasive Thoracic Surgery Market
- Segmentation of Global Minimally Invasive Thoracic Surgery Market By Type (Lobectomy, Wedge Resection, Pneumonectomy, Others)
- Statistical Snap of Global Minimally Invasive Thoracic Surgery Market
- Expansion Analysis of Global Minimally Invasive Thoracic Surgery Market
- Problems and Obstacles in Global Minimally Invasive Thoracic Surgery Market
- Competitive Landscape in the Global Minimally Invasive Thoracic Surgery Market
- Details on Current Investment in Global Minimally Invasive Thoracic Surgery Market
- Competitive Analysis of Global Minimally Invasive Thoracic Surgery Market
- Prominent Players in the Global Minimally Invasive Thoracic Surgery Market
- SWOT Analysis of Global Minimally Invasive Thoracic Surgery Market
- Global Minimally Invasive Thoracic Surgery Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Minimally Invasive Thoracic Surgery Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Minimally Invasive Thoracic Surgery Market
7. Global Minimally Invasive Thoracic Surgery Market, By Type (USD Million) 2021-2034
7.1. Lobectomy
7.2. Wedge Resection
7.3. Pneumonectomy
7.4. Others
8. Global Minimally Invasive Thoracic Surgery Market, (USD Million) 2021-2034
8.1. Global Minimally Invasive Thoracic Surgery Market Size and Market Share
9. Global Minimally Invasive Thoracic Surgery Market, By Region, (USD Million) 2021-2034
9.1. Asia-Pacific
9.1.1. Australia
9.1.2. China
9.1.3. India
9.1.4. Japan
9.1.5. South Korea
9.1.6. Rest of Asia-Pacific
9.2. Europe
9.2.1. France
9.2.2. Germany
9.2.3. Italy
9.2.4. Spain
9.2.5. United Kingdom
9.2.6. Rest of Europe
9.3. Middle East and Africa
9.3.1. Kingdom of Saudi Arabia
9.3.2. United Arab Emirates
9.3.3. Qatar
9.3.4. South Africa
9.3.5. Egypt
9.3.6. Morocco
9.3.7. Nigeria
9.3.8. Rest of Middle-East and Africa
9.4. North America
9.4.1. Canada
9.4.2. Mexico
9.4.3. United States
9.5. Latin America
9.5.1. Argentina
9.5.2. Brazil
9.5.3. Rest of Latin America
10. Company Profile
10.1. Medtronic
10.1.1. Company details
10.1.2. Financial outlook
10.1.3. Product summary
10.1.4. Recent developments
10.2. Dextera Surgical Inc
10.2.1. Company details
10.2.2. Financial outlook
10.2.3. Product summary
10.2.4. Recent developments
10.3. Intuitive surgical Operations, Inc
10.3.1. Company details
10.3.2. Financial outlook
10.3.3. Product summary
10.3.4. Recent developments
10.4. Richard Wolf GmBH
10.4.1. Company details
10.4.2. Financial outlook
10.4.3. Product summary
10.4.4. Recent developments
10.5. Grena Ltd
10.5.1. Company details
10.5.2. Financial outlook
10.5.3. Product summary
10.5.4. Recent developments
10.6. Medela
10.6.1. Company details
10.6.2. Financial outlook
10.6.3. Product summary
10.6.4. Recent developments
10.7. LivaNova PLC
10.7.1. Company details
10.7.2. Financial outlook
10.7.3. Product summary
10.7.4. Recent developments
10.8. Teleflex Incorporated
10.8.1. Company details
10.8.2. Financial outlook
10.8.3. Product summary
10.8.4. Recent developments
10.9. Sklar Surgical Instruments
10.9.1. Company details
10.9.2. Financial outlook
10.9.3. Product summary
10.9.4. Recent developments
10.10. Others
11. Conclusion
12. List of Abbreviations
13. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
